International Consortium on Meningiomas (ICOM)
@icomeningioma.bsky.social
63 followers 24 following 120 posts
ICOM, under the leadership of Dr. Gelareh Zadeh, increases awareness and conducts high quality cutting-edge research on meningiomas.
Posts Media Videos Starter Packs
icomeningioma.bsky.social
Read the systematic review and meta-analysis which evaluates the effect of #GammaKnife #radiosurgery dose-rate on managing intracranial targets, encompassing an assessment of its association with radiation-related toxicity and adverse effects.

bit.ly/3Kt8UWJ
icomeningioma.bsky.social
A new article in @BrainTumourOrg highlights the findings from the Lancet Oncology paper ‘Analysis of TERT association with clinical outcome in #meningiomas: a multi-institutional cohort study’

bit.ly/46CpXhN
icomeningioma.bsky.social
Meet #ICOM member Clara Lopez, a biologist and PhD student driven by a passion for #CancerResearch. From Spain to New Zealand’s Gillies McIndoe Research Institute, she explores #meningiomas to unlock new drug treatments. Outside the lab, she loves playing frisbee with friends.
icomeningioma.bsky.social
This new study highlights the role of #NOTCH3 in mediating fatty acid oxidation in #meningiomas, and a potential mechanism for increased malignant potential of NOTCH3 + meningiomas.

bit.ly/42dfxTc
icomeningioma.bsky.social
What are the correlations between surface marker patterns in #meningiomas, prognosis, and location?

Read more about this recent research in the Journal of Clinical Neuroscience: bit.ly/4mAcTOD
icomeningioma.bsky.social
Findings:
🧠Response #biomarkers are needed for successful #NeuroOncology #immunotherapy trials
🧠Multiple molecular, cellular & radiologic approaches have shown promise
🧠Validation is needed before these biomarkers can be used to inform clinical trials

bit.ly/3Iyxox6
icomeningioma.bsky.social
This study provides regional insight into the molecular landscape of #meningiomas. It found while routine molecular profiling adds value to classification and prognostication, broader implementation may be limited by cost and panel coverage constraints.

bit.ly/3Iuq71e
icomeningioma.bsky.social
Read the new review in #NeuroOncology Advances focusing on recent advances and highlighting the #epidemiological, #pathological, #molecular/genetic, and clinical characteristics of #SpinalMeningiomas.

academic.oup.com/noa/article/...
icomeningioma.bsky.social
In our new special edition, #Immunotherapy for #BrainTumors, Alexander P Landry, Gavin P Dunn, and Michael Lim provide an overview of the current state of neuro-oncologic immunotherapy as covered in the supplement.

academic.oup.com/noa/article/...
icomeningioma.bsky.social
This new review and analysis reveals that #meningiomas can significantly impact #CognitiveFunction, affecting various domains such as memory, executive function, attention, and language. Most of these domains seem to improve postoperatively.

bit.ly/4nn0RJb
icomeningioma.bsky.social
The new supplement on #Immunotherapy for #BrainTumors is now out in #NeuroOncologyAdvances, edited by Alex Landry, Michael Lim, and Gavin Dunn.

Thank you to the authors, peer reviewers, manuscript editors, and Editor-In-Chief @gelarehzadeh.bsky.social.

bit.ly/460ahEQ
icomeningioma.bsky.social
Dr Linda Bi, Dr Ruchit Patel, Dr Chloe Gui, Dr Farshad Nassiri, and Dr Matija Snuderl joined the #Lancet #Oncology “In Conversation with” #podcast to discuss their new papers on #TERTexpression and TERT promoter mutations in #meningiomas.

Listen now: www.thelancet.com/multimedia/p...
icomeningioma.bsky.social
#ICOM & some of our members just published an article investigating the prevalence & prognostic association of #TERT expression in #meningiomas, with implications for diagnosis & treatment: bit.ly/4g8L0LZ

@gelarehzadeh.bsky.social @justinzwang.bsky.social @felixehretmd.bsky.social @syip.bsky.social
icomeningioma.bsky.social
What is the potential for #MolecularProfiling to refine surgical and #radiotherapy decision-making in #meningioma?

Read the recent study in @NatureMedicine:

go.nature.com/3GygVIj
icomeningioma.bsky.social
#BAP1-altered #meningiomas represent a distinct and aggressive CNS tumor subtype associated with PRC dysregulation and recurrent 3p chromosome loss. These findings support the designation “meningioma, BAP1-altered.”

Read full article in #NeuroOncology:

bit.ly/3YWa1CN
icomeningioma.bsky.social
Do you have clinical and research interests in #meningiomas, and want to find out more about becoming an #ICOM member?

Contact us today: bit.ly/3HyhPoD
Interested in becoming an ICOM member?
icomeningioma.bsky.social
Collision tumors are rare. Among these, the metastasis of #melanoma into an intracranial #meningioma is particularly uncommon, with only 4 previously reported cases. This #CaseReport present the 5th documented case.

bit.ly/3HOyZyr
icomeningioma.bsky.social
This new study in Scientific Reports evaluates intracranial pressure in NF2-associated #meningiomas using perioperative #OpticNerveSheath diameter measurements.

Read it now: go.nature.com/4oJWSI7
icomeningioma.bsky.social
Have you read the new edition of our #ICOM newsletter?

In it, you can read about the latest #meningioma-related events and articles from our members.

adobe.ly/45yJe1R
icomeningioma.bsky.social
Read this recent study in the JNS exploring potential correlations between the recurrence rate of #SphenoOrbital #meningiomas and the extent of resection of both the bony tumor portion and soft tumor portion.

bit.ly/4mkxNBL
icomeningioma.bsky.social
Read the new article “Postoperative #radiotherapy in subtotally resected recurrent WHO grade 1 #meningiomas with intermediate-/high-risk molecular profiles” in #NeuroOncology by authors including our #ICOM members:

bit.ly/40wecpJ
icomeningioma.bsky.social
The new edition of our #ICOM newsletter is now out!

Read about the latest #meningioma-related events and articles from our members: adobe.ly/45yJe1R
icomeningioma.bsky.social
A new study, showing that unidimensional tumor measurements and tumor volume assessments show a stronger association with overall survival than bidimensional measurements in recurrent non-benign #meningiomas, is now out in #NeuroOncology Advances:

bit.ly/4l0xrPx
Prognostic value of 1D, 2D and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: radiological post-hoc analysis of the EORTC-BTG-1320 trial 

Julia Furtner, Luzia Berchtold, Emilie Le Rhun, Antonio Silvani, Roberta Rudà, Giuseppe Lombardi, Juan Manuel Sepúlveda-Sánchez, Petter Brandal, Martin Bendszus, Vassilis Golfinopoulos, Thierry Gorlia, Felix Sahm, Wolfgang Wick, Giuseppe Minniti, Michael Weller, Franz König, Matthias Preusser
icomeningioma.bsky.social
Read the Molecular Tumor Board Case Report in #NeuroOncologyAdvances on ‘Somatic SMARCB1 mutation in #SpinalMeningioma represents branched evolution in a patient with multiple sporadic #meningiomas’ now:

bit.ly/41fTPx9